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Virus‐like particles (VLPs) are particulate structures, which are applied as vaccines
or delivery vehicles. VLPs assemble from subunits, named capsomeres, composed of
recombinantly expressed viral structural proteins. During downstream processing,
in vivo‐assembled VLPs are typically dis‐ and reassembled to remove encapsulated
impurities and to improve particle morphology. Disassembly is achieved in a high‐
pH solution and by the addition of a denaturant or reducing agent. The optimal
disassembly conditions depend on the VLP amino acid sequence and structure, thus
requiring material‐consuming disassembly experiments. To this end, we developed a
low‐volume and high‐resolution disassembly screening that provides time‐resolved
insight into the VLP disassembly progress. In this study, two variants of C‐terminally
truncated hepatitis B core antigen were investigated showing different disassembly
behaviors. For both VLPs, the best capsomere yield was achieved at moderately
high urea concentration and pH. Nonetheless, their disassembly behaviors differed
particularly with respect to disassembly rate and aggregation. Based on the high‐
throughput screening results, a diafiltration‐based disassembly process step was
developed. Compared with mixing‐based disassembly, it resulted in higher yields of
up to 0.84 and allowed for integrated purification. This process step was embedded
in a filtration‐based process sequence of disassembly, capsomere separation, and
reassembly, considerably reducing high‐molecular‐weight species.
K E YWORD S
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like particles
1 | INTRODUCTION
Virus‐like particles (VLPs) are multimolecule structures that resemble the
native virus they were derived from, but lack infectious nucleic acids
(Chackerian, 2007). Their particulate and repetitive structure makes
them highly immunogenic, which has been harnessed by several licensed
vaccines, such as VLPs against hepatitis B virus and human papilloma-
virus infection (Bryan et al., 2016; McAleer et al., 1984). Chimeric VLPs
are VLPs which incorporate a foreign antigenic epitope against which an
immune reaction is intended. This has been evaluated in several
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preclinical and clinical trials, and recently, a vaccine against the circum-
sporozoite protein of the malaria pathogen has been locally approved
(European Medicines Agency, 2015). Recent efforts to develop VLP‐
based severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
vaccines underline the flexibility and simplicity of chimeric VLPs
(Ghorbani et al., 2020; Yang et al., 2021). However, the versatile platform
of chimeric VLPs not only comes with promises, but also with funda-
mental challenges, such as the ability to form stable capsids (Borisova
et al., 1999; Böttcher et al., 2006; Nassal et al., 2005; Pumpens & Grens,
2001). Challenges related to the production process include the limited
solubility of candidate molecules (Jegerlehner, 2002; Karpenko et al.,
2000; Vormittag et al., 2020a) and the dependence of process para-
meters on molecular properties, which are both influenced by the amino
acid sequence of the inserted foreign antigenic epitope (Rüdt et al.,
2019). A typical production process is shown in Figure 1a. Process steps
that are influenced by the epitope insertion are, for example, precipita-
tion, where a varying amount of ammonium sulfate is required for VLP
precipitation (Hillebrandt et al., 2020; Vormittag et al., 2020b), and VLP
reassembly, which has been proposed to depend on VLP zeta potential
(Rüdt et al., 2019). VLPs are disassembled (dissociated into capsomeres)
and reassembled (capsomeres triggered to form capsids) to improve
structural homogeneity, stability, and immunogenicity (Zhao, Allen, et al.,
2012; Zhao, Modis, et al., 2012). Disassembly is realized by a high pH and
low ionic strength, often adding denaturants or reducing agents (Bin
Mohamed Suffian et al., 2017; Mach et al., 2006; McCarthy et al., 1998;
Singh & Zlotnick, 2003; Strods et al., 2015; Zhang et al., 2021), while
reassembly is achieved at neutral pH and high ionic strength (Mach et al.,
2006; Zlotnick et al., 1996). As disassembly releases capsid‐internal im-
purities and typically leads to incomplete disassembly or aggregate for-
mation, a capsomere separation step is added between dis‐ and
F IGURE 1 (a) Process of intracellularly produced, in vivo‐assembled capsids, highlighting unique virus‐like particle (VLP) process steps.
Compared with other biotechnological products, upstream processing and primary purification are followed by a sequence of disassembly,
capsomere separation, and reassembly. This sequence allows for the improvement of particle homogeneity and removal of encapsulated
impurities. (b) Concept of a filtration‐based VLP purification cascade. Capsids are disassembled by cross‐flow diafiltration (DF) into a
disassembly buffer while the capsomeres are retained by the membrane. Encapsulated impurities are released during disassembly and washed
out if smaller than the membrane molecular weight cut‐off. Non‐disassembled capsids and potential aggregates are separated by a dead‐end
ultrafiltration step. The capsids are then reassembled in a second cross‐flow DF step into a DF buffer that favors the assembled state [Color
figure can be viewed at wileyonlinelibrary.com]
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reassembly (Zlotnick et al., 1996). As a denaturant, urea has been in-
vestigated at several concentrations for hepatitis B core antigen (HBcAg)
VLP disassembly into HBcAg dimers (capsomeres) (Singh & Zlotnick,
2003; Zhang et al., 2021), further referred to as dimers. These publica-
tions show that an increasing urea concentration leads to a more com-
plete and rapid disassembly, while urea concentrations of ≥4M resulted
in protein denaturation, which, in turn, can lead to aggregation or the
inability to reassemble. It, therefore, seems reasonable to use urea con-
centrations for disassembly which are high enough to maximize the di-
mer yield but do not result in protein denaturation. For chimeric VLPs, it
is conceivable that the inserted epitope influences the optimal dis-
assembly solution conditions. Unpublished results on chimeric HBcAg
disassembly by our laboratory confirm these assumptions.
VLP disassembly is typically achieved by the addition of disassembly
agents (Mach et al., 2006; McCarthy et al., 1998; Singh & Zlotnick, 2003;
Zlotnick et al., 1996), mixing VLP product with a disassembly buffer (Bin
Mohamed Suffian et al., 2017; Lee & Tan, 2008; Liew et al., 2012; Zhang
et al., 2021), or by dialysis (Holmes et al., 2015; Strods et al., 2015). While
mixing is fast, it leads to dilution. Dialysis does not significantly change
the original concentration and has the capability to remove some of the
(encapsulated) impurities through the dialysis membrane (Mach et al.,
2006) but is a slow process (Phillips & Signs, 2004). In recent publications,
we have demonstrated the utility of transferring VLP process steps,
namely capture and VLP reassembly, to a cross‐flow filtration (CFF) unit
(Hillebrandt et al., 2020; Rüdt et al., 2019). Figure 1a shows that these
two process steps frame the disassembly step, which is one of the rea-
sons why it was presumed to be useful to transfer this process step to
cross‐flow diafiltration (DF). As CFF process development is time‐ and
material‐consuming, it can be accelerated if the optimal DF buffer
composition is known before.
In this study, we developed a time‐resolved high‐throughput
disassembly screening for (chimeric) VLP candidates. This ap-
proach aims to reduce the experimental effort to identify optimal
disassembly conditions for different VLPs and for CFF process
development. As candidate VLP material is scarce at an early
stage of process development, it is highly desirable to develop a
screening method which requires a small amount of VLPs. To this
end, we developed a low‐volume, fast, and accurate screening
method that allows for the assessment of VLP dimer yield and
kinetic data based on a high‐performance liquid chromatography
(HPLC) system. Disassembly of a C‐terminally truncated HBcAg
and a chimeric C‐terminally truncated HBcAg VLP with a poly-
histidine tag was investigated (referred to as Cp149 and VLP A,
respectively). Optimal disassembly conditions were selected for
DF process development. This integrated DF process step allows
for disassembly and depletion of impurities simultaneously. Ad-
ditionally, we show that the developed disassembly process step
can be integrated into a filtration‐based sequence of dis-
assembly, dimer separation, and reassembly (Figure 1b). The re-
sults presented in this study underline the influence of inserted
peptides on the optimal conditions for disassembly and demon-
strate the usefulness of the developed high‐throughput screening
method and its transferability to a filtration‐based process.
2 | MATERIALS AND METHODS
2.1 | Materials, buffers, and VLPs
All chemicals were purchased from Merck KGaA, unless otherwise sta-
ted. Solutions and buffers were prepared with ultrapure water (PURE-
LAB Ultra; ELGA LabWater). All buffers were pH‐adjusted with 32% HCl
or 4M NaOH using a SenTix62 pH electrode (WTW) at a HI 3220 pH
meter (Hanna Instruments). Solutions were filtered before use and ana-
lysis through 0.2 µm cellulose acetate (VWR) or Millex‐GV 0.22 µm
polyvinylidene fluoride filters (Merck Millipore), often with glass fiber
pre‐filtration (Minisart GF; Sartorius Stedim Biotech GmbH). The plasmid
for Cp149, a C‐terminally truncated HBcAg protein (amino acids 1 to149
(Zlotnick et al., 1996)), was generously provided by Prof. Adam Zlotnick
(Indiana University). BioNTech Protein Therapeutics GmbH generously
provided the chimeric HBcAg VLP A plasmid. VLP A was C‐terminally
truncated, contained an inserted epitope, and incorporated a C‐terminal
polyhistidine tag, similar as in (Schumacher et al., 2018). The Cp149 and
VLP A protein dimers had a molecular weight of approximately 34 and
40 kDa, respectively. The 280 nm extinction coefficients were derived
from the web‐tool ProtParam (Gasteiger et al., 2005) and were
1.764 L·g−1·cm−1 for Cp149 and 1.558 L·g−1·cm−1 for VLP A. Con-
centrations were calculated using Beer's law and the 280 nm absorbance
peak area derived from size‐exclusion chromatography (SEC) HPLC. The
HBcAg concentration of the VLP feedstock was determined analogously
using the total 280nm absorbance and a NanoDrop 2000c spectrometer
(Thermo Fisher Scientific). HBcAg was expressed in Escherichia coli, lib-
erated by lysis, precipitated and re‐dissolved applying a centrifugation
protocol similarly as described in a recent article (Hillebrandt et al.,
2020). Additionally, the re‐dissolved and sterile‐filtered VLP solution was
purified by DF and multimodal SEC as described in the Supporting In-
formation Section S1.
2.2 | Disassembly buffer compositions
The disassembly time series (DisA‐TS) is a two‐step procedure and de-
scribed in detail in Section 2.3. Briefly, a batch disassembly reaction is
followed by SEC‐HPLC analysis under the same liquid phase conditions
as in the batch reaction. This batch reaction is initiated by mixing equal
volumes of HBcAg VLP solution and disassembly buffer to reach the
target disassembly conditions after mixing. For all conditions, the com-
mon target concentrations were 50mM Tris and 1 g·L−1 HBcAg. Urea
concentrations (curea) and pH were screened in the ranges from 0 to 4M
and pH 7.2 to 9.0, respectively. The selection of the condition ranges was
based on unpublished pre‐experiments and other publications in-
vestigating HBcAg VLPs (Schumacher et al., 2018; Singh & Zlotnick,
2003). Each target condition required a distinct composition of the added
disassembly buffer which was composed of Tris, urea, and titrant.
Therefore, the required titrant concentration (ctitrant) of each disassembly
buffer was determined to eventually reach the target pH after mixing
with VLP solution. The procedure of this disassembly buffer composition
determination is explained in Figure 2a. It was assumed that the protein
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buffer capacity of HBcAg at a concentration of 1 g·L−1 is negligible. Under
this assumption, 50mM Tris at pH 7.2 was used to mimic the VLP so-
lution and thereby minimize the VLP (product) consumption. The ex-
periments were performed in duplicates and at a 200mL scale to
minimize pipetting errors. The results were exemplarily confirmed by
mixing VLP solution and disassembly buffer at a 200 µL scale and mea-
suring the resulting pH using an Orion PerpHecT ROSS combination
microelectrode (Thermo Fisher Scientific).
2.3 | DisA‐TS and disassembly on column
(DisA‐OC)
The DisA‐TS is a hybrid disassembly screening in nature. It consists
of a batch disassembly reaction followed by SEC‐HPLC analyses.
During the latter, the disassembly reaction continues until detection,
similar to the on‐column disassembly reaction described below. The
time series was started at time t0 by adding 250 µL disassembly
buffer to 250 µL VLP solution in a 2.2mL deep‐well plate (VWR) in
intervals of 7.5 min between each well. The mixtures were incubated
at 23°C and repeatedly analyzed by SEC‐HPLC over a period of 24 h
at times ti (Figure 2b). Analytical SEC was performed with 20 µL
injections on an AdvanceBio SEC 300 Å, 4.6 × 150mm, 2.7 μm col-
umn (Agilent Technologies) at a Dionex Ultimate 3000 RS UHPLC
system with a diode array detector controlled by Chromeleon ver-
sion 6.8 SR15 (Thermo Fisher Scientific). The mobile phase was
adapted to the sample's target disassembly condition, and a flow rate
of 0.35mL·min−1 was applied. Samples at pH 9.0 were analyzed at pH
8.0 due to the limited pH compatibility of the column. The efficiency
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F IGURE 2 Schematic of the developed
screening procedures. The large gray boxes
represent mixtures of solutions represented by
smaller boxes. (a) A separate experiment is
required to determine each disassembly buffer
composition by titration. First, VLP solutiona is
mixed with pH‐unadjusted (non‐titrated)
disassembly buffer. Second, the mixture is
titrated to the target pH (pHtarget) and the
required amount of titrant (either NaOH or HCl)
is used to determine the titrant concentration of
the final disassembly buffer ctitrant. (b) The DisA‐
TS is started at time t0 by mixing VLP solution
with an equal volume of disassembly buffer to
achieve the target disassembly condition.
Samples are repeatedly drawn at times
=t i( 1, 2, ...,12)i and analyzed by SEC‐HPLC.
The obtained results are assigned to
= +t t t̄Δi ret, where t̄ret is the average SEC‐
HPLC retention time of the dimer peak. (c) The
DisA‐OC is started by injecting VLP solution
onto the SEC‐HPLC column under disassembly
conditions at time t0 without prior mixing or
pre‐experiments. The obtained SEC‐HPLC
results are assigned to =t t + t̄Δ0 ret.
aAt low
target HBcAg concentrations of up to
approximately 1 g·L−1, the protein buffer
capacity is negligible. Therefore, the
determination of the disassembly buffer
composition can be performed with VLP
solution with zero HBcAg concentration, i.e. 50
mM Tris, pH 7.2 buffer. c , concentration; DisA‐
OC, disassembly on column; DisA‐TS,
disassembly time series; HBcAg, hepatitis B core
antigen; HPLC, high‐performance liquid
chromatography; SEC, size‐exclusion
chromatography; VLP, virus‐like particle; t , point
in time [Color figure can be viewed at
wileyonlinelibrary.com]
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where c t( )dimer,tot is the total dimer concentration at the time t after
start of the disassembly at t0. Furthermore, c t¯ ( )VLP 0 and c t¯ ( )dimer 0 are
the mean initial concentrations of HBcAg VLPs and dimers, respec-
tively, which are present in the VLP feedstock prior to the dis-
assembly reaction. Mean concentrations from 28 samples of the VLP
solution at 1 g·L−1 HBcAg were determined by SEC‐HPLC as de-
scribed above but with 50mM Tris at pH 7.2 as mobile phase. During
the 24 h DisA‐TS, evaporation was observed. To estimate an average
volumetric evaporation rate, the total HBcAg concentration of a VLP
solution was analyzed twice with an interval of 20 h. The mean
evaporation rate was then converted into evaporation correction












where c t~ ( )dimer,tot is the measured concentration during the DisA‐TS.
A derivation of f t( )v and Equation (2) can be found in Appendix A.
To investigate the disassembly reaction with a shorter time in-
terval and without prior mixing or batch disassembly, the above-
mentioned SEC‐HPLC method was used as an additional screening
tool. This approach is in the following referred to as DisA‐OC and
shown in Figure 2c. To this end, a VLP solution with 1 g·L−1 HBcAg
(50mM Tris, pH 7.2) was analyzed by SEC‐HPLC applying the same
flow rate and mobile phases at target disassembly conditions as
described above. For our SEC‐HPLC setup, we determined the ob-
served time interval = − =t t tΔ¯ ¯ 3.36 minret ret inj , where t̄ret is the
average retention time of the dimer peak over all experiments and tinj
is the injection time. For DisA‐OC, the start of the disassembly was
defined as =t t .0 inj
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In the following, we define ‐k0,DisA TS as the rate obtained by DisA‐TS
at = +t t tΔ¯1 ret and ‐k0,DisA OC as the rate obtained by DisA‐OC at
= +t t tΔ¯0 ret, where t1 is the time of the first sampling after ap-
proximately 30min.
2.4 | Filtration‐based disassembly, dimer
separation, and reassembly
The sequential process of disassembly, dimer separation, and re-
assembly was realized in three steps as shown in Figure 1b. Step
(I) was DF‐based disassembly into a disassembly buffer using a
10 kDa molecular weight cut‐off (MWCO), 88 cm2 Ultracel Pellicon 3
membrane (Merck Millipore) followed by an 18 h overnight hold at
5°C and subsequently by filtration through a 0.2 µm pore size cel-
lulose acetate syringe filter (VWR). Note, that urea concentration
and pH of the DF disassembly buffer were at target disassembly
conditions. Step (II) consisted of dimer separation by dead‐end ul-
trafiltration using Vivaspin Turbo 15 RC centrifugal filters with
100 kDa MWCO regenerated cellulose membranes (Sartorius Stedim
Biotech GmbH). The disassembly solution was split into six cen-
trifugal filters, which were operated at a relative centrifugal force of
1000 for 15min, and the product was collected in the filtrate/
permeate. The remaining retentate was equally reprocessed with a
new filter. Step (III) was DF‐based reassembly into 50mM Tris buffer
at pH 7.2 with 650mM NaCl using a 10 kDa MWCO, 200 cm2 Sar-
tocon Slice 200 (Sartorius Stedim Biotech GmbH) where the product
was collected from the retentate. Both DF process steps were rea-
lized on a KrosFlo Research KRIIi CFF system (Spectrum Labs) at a
constant volume of 30mL, a feed flow rate of 30mL·min−1, and
permeate flow rate control at 2mL·min−1 as implemented previously
(Hillebrandt et al., 2020). The corresponding permeate flux setpoints
were 13.6 and 6.0 L·m−2·h−1 for disassembly and reassembly, re-
spectively. The whole process was performed at room temperature
(22.5 ± 0.5°C), unless otherwise stated.
At‐line analysis of DF‐based disassembly was performed analogously
to the HPLC method in the DisA‐TS. The mobile phase composition was
adapted to the current theoretical buffer composition in the retentate.
This was realized by mixing (A) 50mM Tris at pH 7.2 with (B) the DF
disassembly buffer. Assuming ideal mixing and unrestricted permeability
of urea during DF, the fraction of (B) equals − −e1 DV , where DV re-
presents exchanged DF volumes (Kurnik et al., 1995). Feed and re-
assembly samples were analyzed with a Bio SEC‐5 1000Å, 4.6 ×300mm,
5 µm column (Agilent Technologies), at a flow rate of 0.4mL·min−1, and in
50mM Tris at pH 7.2 as mobile phase. Dimer separation samples were
analyzed using the same column with the DF disassembly buffer as
mobile phase. The resulting dimer concentrations before and after dimer
separation were used to calculate the apparent retention coefficient of








The dimer concentrations after disassembly/hold (cdimer,DisA) and
after dimer separation (cdimer,Sep) represent the bulk (feed) and
permeate concentrations, respectively.
3 | RESULTS AND DISCUSSION
DisA‐Ts: The long‐term development of the disassembly reaction was
monitored using an initial batch disassembly reaction followed by 12
SEC‐HPLC analyses over a time period of 24 h. The time series was
initiated by mixing equal volumes of VLP solution and disassembly buffer
(Figure 2b). The ionic strength of this mixture is different from the ones
of the individual solutions before mixing. The ionic strength of a solution
influences the pKa of weak acids/bases, such as Tris, and ultimately the
solution pH (Beynon & Easterby, 1996). Therefore, the pH does not
change linearly with the volume shares upon mixing of VLP solution and
disassembly buffer. This nonlinear behavior is not expected for non‐
dissociating species, such as urea in this screening. Next to the ionic
strength, the urea concentration influences the pH of aqueous solutions
(Bull et al., 1964). Instead of correcting the pH of the mixture by titration,
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the exact amount of titrant was determined beforehand in a separate
experiment (Figure 2a). The disassembly buffer for the DisA‐TS was then
prepared according to the results of this experiment. Reaction analysis
was carried out by an SEC‐HPLC method, where the mobile phase
composition was the same as the examined disassembly reaction con-
ditions. Compared with using a standard analysis mobile phase, the dis-
assembly reaction is less influenced using the mobile phase at
disassembly conditions. The selected 300Å pore size SEC‐HPLC column
led to separation of VLPs, dimers (capsomeres), and lower‐molecular‐
weight species (LMWS) such as buffer substances, host cell proteins, and
nucleic acids while ensuring a short total analysis time of 7.5min. For a
particular disassembly condition, this enabled the analysis of four bat-
ches, here two different VLPs in duplicates, with a time interval of 30min
between each sampling.
DisA‐OC: For determining initial disassembly rates, the above-
mentioned SEC‐HPLC method was directly used as a screening tool
(Figure 2c). Here, one needs to keep in mind that the reaction con-
ditions are slightly different from the SEC‐HPLC analysis in the DisA‐
TS, due to the unprocessed nature of the sample (pH 7.2, no urea)
and the immediate fractionation of the sample composition based on
size and structure of the molecules.
3.1 | Disassembly rate
Regarding the DisA‐TS results, the slope of the dimer yield between
the first measured sample ( + Δ ≈t t̄ 33.36 min1 ret ) and the starting
VLP solution (t0) can be converted into an approximate initial dis-
assembly rate ‐k0,DisA TS (Equation 3). For a better temporal resolution
of the initial disassembly rate, the described SEC‐HPLC method was
used as a screening tool (DisA‐OC) reducing the investigated reac-
tion interval to the mean dimer retention time Δ =t̄ 3.36 minret .
Here, VLPs in neutral buffer were directly injected into the mobile
phase at disassembly conditions, resulting in an on‐column dis-
assembly reaction. Figure 3 shows a comparison of the two experi-
mentally determined disassembly rates. While ‐k0,DisA OC increased to
4.7 g·L−1·h−1 for Cp149 and to 7.3 g·L−1·h−1 for VLP A, ‐k0,DisA TS was
1.1 g·L−1·h−1 at most, confirming that ‐k0,DisA OC is a more accurate
representation of the initial disassembly rate. Comparing the two
screening methods for Cp149, ‐k0,DisA OC below 1.0 g·L
−1·h−1 resulted
in a similar corresponding ‐k0,DisA TS. This behavior is expected if
‐k0,DisA TS is a good representation of the actual initial disassembly
rate in the first approximately 33min. In this study, this is the case if
the initial disassembly rate is smaller than 2 g·L−1·h−1 and approxi-
mately constant during the observed interval, as the DisA‐TS results
for Cp149 in Figure 4a suggest. In contrast to Cp149, VLP A showed
a steeply increasing dimer yield at the beginning which rapidly flat-
tened out afterward approaching equilibrium (Figure 4), resulting in
larger ‐k0,DisA OC (Figure 3). For fast disassembly reactions such as for
VLP A, ‐k0,DisA OC and especially ‐k0,DisA TS are determined by dimer
concentrations close to the equilibrium. This is why both could po-
tentially serve as a predictive tool to find disassembly‐competent
VLP candidates or suggest a promising condition range for screening.
Here, the experimental effort, resources, and time for a DisA‐OC
experiment would be significantly lower than for the DisA‐TS. For
example, the disassembly rates of 96 VLP candidates can be
screened for one disassembly condition within 24 h.
3.2 | DisA‐TS
The developed DisA‐TS was applied to investigate the effect of
varying curea, pH, and the combination of both on HBcAg VLP dis-
assembly. From a process development perspective, a high yield
obtained in reasonable process time, including knowledge about a
potential operating window, is desirable. It is, therefore, interesting
to observe the dimer yield in a time frame of 24 h.
3.2.1 | Urea screening
Figure 4a shows the dimer yield of Cp149 and VLP A at pH 7.2 and
varying curea over time. It has to be noted that the pre‐disassembly
VLP stock solution also was at pH 7.2 but contained no urea. For
F IGURE 3 Comparison of the disassembly rates from disassembly time series ( ‐k0,DisA TS) and from disassembly on column ( ‐k ,0 DisA OC) at
varying pH and urea concentration. The dashed line indicates equal values of ‐k0,DisA TS and ‐k ,0 DisA OC. Standard deviations of duplicate
measurements are not shown to enhance readability. They were below 0.02 g·L−1·h−1 for ‐k0,DisA TS and below 0.18 g·L
−1·h−1 for ‐k ,0 DisA OC
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F IGURE 4 Screening of curea and pH by DisA‐TS. Error bars represent the standard deviation of duplicate measurements, and dashed lines
were added to guide the eye. (a) DisA‐TS of curea at the same pH as the VLP solution before disassembly, pH 7.2. (b) DisA‐TS of pH at a curea of
3M (shades of blue) and without urea (shades of black). (c) Combined screening of curea and pH by DisA‐TS. The gray box indicates the position
of the magnification shown in the inserted plot. curea, urea concentration; DisA‐TS, disassembly time series; VLP, virus‐like particle [Color figure
can be viewed at wileyonlinelibrary.com]
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Cp149, this condition already resulted in the presence of HBcAg
dimers, indicated by an initial dimer yield of 0.07, as similarly ob-
served previously (Singh & Zlotnick, 2003). At the beginning of the
reaction ( ≤t 6 h), the dimer yield increased for all experiments,
where a larger curea led to a stronger increase. After this initial
period, the dimer yield still increased for ≤c 3 Murea , stagnated for
=c 3.5 Murea , and decreased for =c 4 Murea from a maximum of 0.65
to 0.63. Interestingly, ≥c 3 Murea led to a faster yield increase but
resulted in a similar final dimer yield of 0.62 at 24 h. VLP A dis-
assembly was at a generally lower level for these conditions. The
highest dimer yield after 24 h was observed for =c 3 Murea . Similar to
Cp149, the dimer yields for a higher curea increased to a maximum
before they declined. This effect was more pronounced for VLP A
than for Cp149 and was strongest for =c 4 Murea , where the max-
imum dimer yield of 0.27 was reached after 1.5 h, after which it
decreased to 0.11 after 24 h. When dimer aggregation occurs, ag-
gregate species are expected to have a higher molecular weight and
therefore elute earlier than dimers in SEC‐HPLC. Considering SEC‐
HPLC chromatograms of these samples (Supporting Information
Figure S1), the decline in dimer yield was accompanied by a con-
centration increase of high‐molecular‐weight species (HMWS),
pointing toward aggregation. This suggests that VLP A is more sus-
ceptible to urea‐based degradation. VLP A differs from Cp149 by the
inclusion of a C‐terminal His‐tag and the integration of an epitope
into the spike tip of the protein. The spike tip insertion could have an
impact on dimer stability and thus influence its susceptibility toward
urea degradation. The generally higher dimer yield at equal solution
conditions for Cp149 as compared with VLP A might also be influ-
enced by the inserted epitope, as an influence of insertions on VLP
assembly and stability has been shown (Billaud et al., 2005;
Karpenko et al., 2000). Interestingly, it has been reported that the
addition of a C‐terminal polyhistidine tag leads to stabilized VLP
structures that are more resilient toward mechanical and chemical
stress (Schumacher et al., 2018). As a chemical stress, disassembly
may be hampered by the addition of a C‐terminal polyhistidine tag,
which could explain the lower dimer yields for VLP A as compared
with Cp149 as observed at pH 7.2.
3.2.2 | pH screening
Figure 4b presents data of pH screenings at =c 0 Murea and
=c 3 Murea for Cp149 and VLP A. For both VLPs and curea, the dimer
yield increased until 6 to 8 h. For most experiments, the dimer yield
subsequently remained approximately constant. Experiments with-
out urea and a pH ≥8.5 as well as =c 3 Murea , pH 7.2 showed a dimer
yield increase from 8 to 24 h. For high pH and curea, a slight decrease
in dimer yield was observed. However, this decrease was less pro-
nounced than for the experiments at =c 4 Murea , as described above.
An interesting observation is that for =c 3 Murea , the experiment at
pH 9.0, compared with the experiment at pH 8.5, showed slightly
lower dimer yields for Cp149 and significantly lower dimer yields for
VLP A. This decrease was probably caused by aggregation. This is
supported by chromatograms of the pH 9 experiment, showing in-
creased peak areas for HMWS (data not shown). In both experi-
mental series, VLP A dimer yield increased faster relative to its
respective maximum dimer yield. As explained above, Cp149 is
substantially more inclined to disassemble at pH 7.2 while the ex-
periments at pH >7.2 did not result in a comparable trend, showing a
more similar disassembly progress for VLP A and Cp149. Except for
mild and aggregate‐promoting conditions, dimer yields showed a
plateau toward the end of the DisA‐TS (24 h), as observed previously
(Singh & Zlotnick, 2003).
3.2.3 | Synergistic effects
The combination of increasing pH and curea generally led to higher
dimer yields as compared with pH or curea increase alone. Figure 4c
shows Cp149 and VLP A dimer yield over time for various combi-
nations of high pH (pH 8 to 9) and curea (2.5 to 3.5M). A magnification
of the figure reveals that for Cp149, high curea and pH led to a
steeper yield increase, which, however, resulted in similar final dimer
yields of 0.66 to 0.71 after 24 h. For VLP A, this general trend is not
applicable. VLP A showed yield decreases over the time course of the
experiments at pH ≥ 8.5, indicating aggregation. Final dimer yields
ranged from 0.56 to 0.69, where the highest final yield was observed
for pH 8.5 and =c 3 Murea . Generally, it has to be noted that dimer
yields below 1 are commonly observed for disassembly of in vivo‐
assembled VLPs, for example, 0.58 to 0.89 in a recent publication
(Zhang et al., 2021). This behavior is expected for in vivo‐assembled
VLPs, where dis‐ and reassembly aim to remove inactive protein
(Zlotnick et al., 2002).
A comprehensive overview of the impact of reaction conditions
on maximum dimer yield and ‐k0,DisA OC is given in Figure 5. While
‐k0,DisA OC was similar for Cp149 and VLP A at pH 7.2, the maximum
dimer yield was significantly higher for Cp149. At higher pH and curea,
dimer yields were comparable between Cp149 and VLP A, while
‐k0,DisA OC was generally higher for VLP A. This illustrates that not only
the dimer yield but also ‐k0,DisA OC is influenced by the molecular
structure of the VLP, in this case, the insertion of a foreign epitope
and addition of a C‐terminal polyhistidine tag for VLP A. In essence,
the screening experiments showed that higher pH and curea lead to
higher dimer yields, which is, however, limited by aggregation,
especially for VLP A and at pH 9. The highest dimer yields after 24 h
were 0.71 for Cp149 and 0.69 for VLP A, achieved at pH 8.5,
=c 3.5 Murea and pH 8.5, =c 3 Murea , respectively.
3.3 | Filtration‐based dis‐ and reassembly
At a 30mL scale, DF‐based disassembly of Cp149 and VLP A was
performed, followed by an 18 h overnight hold, a dimer separation
step by dead‐end filtration, and DF‐based VLP reassembly
(Figure 1b). In this study, disassembly is achieved by buffer exchange
of 6 diafiltration volumes (DV) into the DF disassembly buffer, which
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is completed after approximately 90min considering a permeate
flow rate of 2 mL·min−1. An advantage of DF over other disassembly
methods is the simultaneous increase in disassembly buffer compo-
nent concentration and depletion of undesired LMWS (10 kDa
MWCO), such as impurities or VLP stability‐enhancing salts from
previous process steps. This has implications on the design of the
DisA‐TS and the interested reader is referred to the Supporting In-
formation Section S2. The MWCO selection was based on previous
work (Rüdt et al., 2019) and provided full retention of dimers under
the conditions used in this study. The conditions for DF‐based dis-
assembly were chosen based on the highest dimer yield in the DisA‐
TS, regardless of disassembly rate ‐k0,DisA OC (Section 3.1). Considering
the expected DF process times and the implementation of an over-
night hold, faster disassembly, that is, larger ‐k0,DisA OC, does not result
in a significant advantage. Therefore, the disassembly process step
was conducted at a target HBcAg concentration of 1 g·L−1, pH 8.5,
and =c 3.5 Murea for Cp149, or =c 3 Murea for VLP A. Another, more
differentiated consideration could be the preference of lower pH and
urea concentration but a similar dimer yield to prevent “alkaline
stress” and to save resources. The results of the DisA‐TS revealed
that the dimer yield typically continues to increase after 90min,
which is the process time of DF‐based disassembly. Therefore, a hold
step was implemented after this process step. Another finding of the
DisA‐TS was that the highest dimer yields are often concomitant
with a yield decrease toward the end of the observed 24 h period,
especially for VLP A. In pre‐experiments for VLP A, the overnight
hold at room temperature resulted in a turbid solution that clogged a
0.2 µm pore size filter, indicating aggregation (data not shown). The
turbidity of the process solution was avoided by cooling to 5°C
during the hold step and was implemented in all presented pro-
cesses. Another potential measure to prevent aggregation is the
supplementation of the disassembly buffer with additives such as
NaCl (Singh & Zlotnick, 2003), glycerol (Schumacher et al., 2018), or
surfactants (Shi et al., 2005). A screening for additives and their
optimal concentration could easily be performed using the developed
DisA‐TS method, which is, however, out of the scope of this study. As
observed in the DisA‐TS, the highest dimer yield was 0.71. The
remainder of the protein is regarded as inactive protein and is
therefore removed in a separation step (Zlotnick et al., 1996, 2002).
Here, dead‐end filtration with a 0.2 µm syringe filter and a 100 kDa
MWCO membrane aimed for removal of undesired species with
higher molecular weight than dimers. The MWCO of 100 kDa was
selected as it successfully retained VLPs during the preceding
purification (Supporting Information Section S1). The permeation of di-
mers through the centrifugal filter membrane was confirmed by
SEC‐HPLC in a preliminary test (data not shown). For the subsequent
VLP reassembly, DF has proven to be a valuable tool (Liew et al., 2012;
Rüdt et al., 2019) and was therefore applied for 3DV in this study.
3.4 | At‐line monitoring of DF‐based disassembly
Figure 6 shows the DF‐based dimer yield over process time
determined by at‐line SEC‐HPLC. The mobile phase conditions
were adapted to the current theoretical buffer composition in the
retentate of the CFF unit (Section 2.4) aiming for a minimal bias of
the analysis procedure with regard to the measured dimer yield. The
same theoretical 280 nm extinction coefficient was used for all mo-
bile phases in this study. It has to be noted that the absorption of
proteins at 280 nm increases with increasing urea concentration
(Pace et al., 1995) and thereby leads to a relative overestimation
of the protein concentration for samples with higher urea
F IGURE 5 Effect of screening conditions on ‐k ,0 DisA OC and total dimer yield of Cp149 and VLP A. The center of each bubble determines the
screening conditions, urea concentration, and pH. The color intensity and the area of a bubble represent ‐k ,0 DisA OC and the maximum of the total
dimer yield, respectively. Note that the DisA‐OC approach was not performed for conditions at pH 9 due to the pH limit of the SEC‐HPLC
column. Bubbles of conditions which did not allow for ‐k ,0 DisA OC determination are transparent and marked with a black “X.” DisA‐OC,
disassembly on column; HPLC, high‐performance liquid chromatography; ‐k ,0 DisA OC, disassembly rate from disassembly on column; SEC, size‐
exclusion chromatography [Color figure can be viewed at wileyonlinelibrary.com]
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concentration, which was considered negligible for this study.
Compared with DisA‐TS, Figure 6 shows a 19%‐increased initial
(feed) dimer yield for Cp149. The feed solutions were frozen at
larger scale than for the DisA‐TS, most probably leading to a more
pronounced freeze/thaw instability of Cp149 VLPs (Schumacher
et al., 2018). The dimer yields at the end of the DF (1.4 h) were 0.73
for Cp149 and 0.77 for VLP A, which are higher compared with the
DisA‐TS results after 1.6 h with 0.70 and 0.69, respectively. The in-
creased dimer yields for DF‐based disassembly may result from the
slower change of solution conditions avoiding urea concentration
peaks or are due to intensified mixing by CFF.
3.5 | Process data of the filtration‐based process
sequence
In addition to at‐line analysis for dimer quantification during dis-
assembly, all process steps were analyzed by off‐line SEC‐HPLC
using a 1000 Å pore size column. This column allowed for a better
separation and quantification of differently sized species as com-
pared with the column used in the disassembly screening. Besides
VLPs and dimers, a peak with HMWS larger than VLPs was detected.
As already shown in a previous study (Hillebrandt et al., 2020), these
HMWS are expected to be forms of HBcAg, such as partially re-
versible aggregates of VLPs or dimers (Newman et al., 2009;
Schumacher et al., 2018), as mainly dimers are detected after dis-
assembly. The recovered mass of each species after each process
step is listed in Table 1. Besides the aforementioned species, a
shoulder of the dimer peak and LMWS were detected in the 280 nm
chromatogram. According to their ultraviolet light spectra, the dimer
shoulder is a protein species, which could constitute aggregated or
partially unfolded forms (Samandoulgou et al., 2015) of the HBcAg
dimers. According to their ultraviolet light spectra, the LMWS are a
mixture of nucleic acids, buffer species, and/or proteins (data not
shown). The content (by peak area) of LMWS after reassembly was
1.8% for Cp149 and 6.4% for VLP A while the dimer shoulder con-
tent was 4.0% and 0%, respectively. As no clear trend was observed,
both species were not further investigated.
During the 5°C overnight hold, the Cp149 dimer yield further
increased from 0.73 (Figure 6) to 0.84 (Table 1) showing no HMWS
or VLPs. A potential reason for the higher dimer yield is the
temperature‐related pH increase. The strong temperature depen-
dence of the Tris pKa (Beynon & Easterby, 1996) resulted in a
measured increase of ~0.3 pH units for the used DF disassembly
buffer. Furthermore, decreasing the temperature might increase the
extent of disassembly as the opposite reaction, that is, VLP assembly,
is favored at higher temperature (Ceres & Zlotnick, 2002). Due to the
cooling costs and the long downtime, the overnight hold seems not
profitable at a larger scale and an immediate continuation of the
process is suggested in this case. Note, that a potential yield loss due
to the 0.2 µm filtration is included in the aforementioned yields and
was not separately investigated. For the dimer separation step, the
apparent retention coefficient of dimers Rdimer was determined under
F IGURE 6 Total dimer yield determined by at‐line SEC‐HPLC
during DF‐based disassembly. The samples were taken at every DV,
and the analysis was completed after a median duration of 13min.
Dashed lines were added to guide the eye. DF, diafiltration;
DV, diavolume; HPLC, high‐performance liquid chromatography;
SEC, size‐exclusion chromatography [Color figure can be viewed at
wileyonlinelibrary.com]













mg mg mg ‐ g·L−1 ‐
Cp149
Feed 1.17 15.89 6.93 0.82 0.61
Disassembly
and hold
0 0 20.04 0.84 0.67 0.55
Dimer separation 0 0 16.33 0.82 0.60 0.55
Reassembly 0.22 14.19 1.59 0.87 0.46 0.61
VLP A
Feed 10.65 13.71 0.08 0.84 0.67
Disassembly
and hold
0.20 1.06 17.76 0.73 0.62 0.56
Dimer separation 0.11 0.21 13.91 0.78 0.51 0.56
Reassembly 0.31 7.90 0.87 0.57 0.26 0.63
Note: The product species differ between process steps. HMWS, VLPs,
and dimers are regarded as product species of the feed, while dimers are
regarded as product species of disassembly and hold and dimer
separation. For reassembly, VLPs are regarded as product species. The
recovered product species mass of each step is shown in bold. Step yield,
concentration, and A260/A280 refer to the product species of each step.
Abbreviations: A260/A280, 260 to 280 nm absorbance peak area ratio;
conc., concentration; HMWS, high‐molecular‐weight species;
VLP, virus‐like particle.
aRefers to the step product species (see “Note”).
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process conditions. Based on the results in Table 1, Rdimer was 0.10
for Cp149 and 0.18 for VLP A. The higher retention of VLP A dimers
probably results from the higher level of HMWS. The retained
HMWS can build up a fouling layer that has been shown to influence
the overall selectivity of a fouled membrane in the case of albumins
(Meireles et al., 1991). Another possible explanation could be in-
teraction phenomena resulting from different molecular properties
of VLP A compared with Cp149, for example, size, shape, charge, or
hydrophobicity. Overall, Rdimer describes the real dimer retention
under process conditions not solely the ideal dimer retention of the
selected membrane. The dimer separation MWCO was not optimized
but membranes with a higher MWCO are expected to increase the
dimer yield (decreaseRdimer) while a lower MWCOmight improve the
HMWS removal (and vice versa).
The filtration‐based process sequence resulted in 14.19mg of
reassembled Cp149 VLPs and 7.90mg of VLP A, reducing the HMWS
content by 0.95mg (81%) and 10.34mg (97%), respectively. An in-
teresting observation was that the process with VLP A produced
more dimer than VLP was present in the feed solution, indicating
that HMWS are, at least partially, disassembly‐competent. Product
loss during DF‐based disassembly, dimer separation, and reassembly
was presumably caused by adsorption to the membrane, hold‐up
volumes, and aggregation. As already observed in the DisA‐TS, VLP A
showed a greater tendency to aggregate. Next to the disassembly
process, aggregation challenges have also been reported for re-
assembly (Ding et al., 2010; Rüdt et al., 2019). For the interested
reader, a detailed interpretation of the VLP A product loss can be
found in the Supporting Information Section S3.
The disassembly experiments showed an initial increase of the
transmembrane pressure (Supporting Information Figure S2). As this
pressure increase is concomitant with the degree of buffer exchange
and comparably constant toward the end, it can most probably be
attributed to the viscosity increase (van Reis & Zydney, 2010) due to
the increasing urea concentration (Kawahara & Tanford, 1966). Re-
assembly experiments showed slightly decreasing transmembrane
pressures over time (Supporting Information Figure S2). Overall, DF‐
based dis‐ and reassembly resulted in low mean transmembrane
pressures of 0.15 and 0.10 bar, respectively, with mean absolute
deviations of 0.01 bar for each run. For both membranes, cleaning
according to the manufacturer's instructions recovered the water
permeabilities compared with the ones before the experiment (note
that new membranes were conditioned during pre‐experiments to
avoid yield or permeability loss due to adsorptive effects). To this
end, membrane fouling had no noticeable effect on the filtration
performance and was not irreversible. Nevertheless, the permeate
flux and membrane loading (amount of retained solutes per mem-
brane area) were comparably low (Liew et al., 2012; Rosenberg et al.,
2009; Rüdt et al., 2019; van Reis et al., 1997) and not optimized in
this study. Hence, membrane fouling and product quality should be
carefully investigated when these parameters are increased for
economic reasons.
The 260 to 280 nm absorbance ratio (A260/A280) is an indicator
for the nucleic acid content in a protein solution (Layne, 1957;
Porterfield & Zlotnick, 2010) but is also influenced by the solution
conditions, such as the urea concentration (Donovan, 1969; Pace
et al., 1995). Therefore, only samples analyzed under the same so-
lution conditions can be compared, which are feed and reassembly as
well as disassembly/hold and dimer separation. For Cp149, the
A260/A280 was equal for these pairs (Table 1). It was 0.61 for the
feed and after VLP reassembly, where 0.60 was previously regarded
as pure non‐truncated HBcAg monomer in water, based on theore-
tical considerations (Porterfield & Zlotnick, 2010). The A260/A280
of dimers after disassembly was 0.55 for Cp149 and 0.56 for VLP A
and remained constant after dimer separation. The Cp149 A260/
A280 is comparable to 0.57 obtained by affinity chromatography at a
urea concentration of 4 M (Zhang et al., 2021). The A260/A280 of
the VLP A feed was 0.67 and was decreased to 0.63 after re-
assembly, indicating the removal of nucleic acids. It is important to
mention that the feed A260/A280 in Table 1 is calculated based on
the peak areas of HMWS, VLPs, and dimers while it was 0.64 for the
VLP peak, suggesting that the depleted nucleic acids were mainly
associated with (or bound to) the HMWS. This was also observed in a
recent study with murine polyomavirus VLPs (Gerstweiler et al.,
2021). Both VLPs used in this study lack the C‐terminal protamine‐
like region of the wild‐type HBcAg, which reduces packaging of nu-
cleic acids (Crowther et al., 1994; Zlotnick et al., 1997). Considering
VLPs with a higher nucleic acid burden, the developed process se-
quence could demonstrate even better separation capacities. For
further improvement of the purification performance, strongly
bound nucleic acids could be digested by a nuclease after
disassembly (Zhang et al., 2021) and nucleotides washed out as
described previously (Hillebrandt et al., 2020). Another reason for
dis‐ and reassembly lies in the improvement of particle structure and
homogeneity (Mach et al., 2006; Zhao, Allen, et al., 2012). This could
be shown, especially for VLP A, by the reduction of the HMWS
content, suggesting improved VLP homogeneity.
In summary, the filtration‐based process sequence has proven
efficient in the realization of dis‐ and reassembly, depleting im-
purities, and decreasing the HMWS content. An observation during
DF‐based reassembly was the presence of a small fraction of un-
assembled protein at the end of the process. A polishing step by
flow‐through multimodal SEC (Hillebrandt et al., 2020) or an in-
tegrated formulation step by DF are conceivable. The integrated
formulation step could simultaneously deplete residual unassembled
protein and LMWS by appropriate choice of the MWCO, for ex-
ample, 300 kDa.
4 | CONCLUSIONS
In this study, we developed a low‐volume and high‐resolution
screening for VLP disassembly conditions. Regarding time and ma-
terial consumption, this method allows for an efficient determination
of the dimer yield and kinetic data of VLPs and is thereby a powerful
tool to accelerate VLP downstream process development. Two
method variants were developed, one with minimal impact on the
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disassembly conditions and therefore resulting in an accurate de-
scription of the disassembly reaction. Another variant, DisA‐OC, al-
lows for higher throughput serving as an indicator for VLP
disassembly efficiency of the tested solutions. A synergistic effect of
pH and urea on the dimer yield was shown for both investigated
in vivo‐assembled HBcAg VLPs, whereas differences in disassembly
rate and aggregation tendency were observed. In the second part of
this study, a filtration‐based downstream process for VLPs was de-
veloped focusing on DF‐based disassembly. Here, the optimized
disassembly conditions derived from the high‐throughput screening
were applied and achieved even higher dimer yields of up to 0.84 and
a simultaneous reduction of nucleic acids. In the following process
steps, capsomeres (HBcAg dimers) were separated from larger spe-
cies and successfully reassembled to VLPs proving the feasibility of a
solely filtration‐based VLP downstream processing. The pre-
dominantly size‐based separations in this approach promise a simple
transfer to other chimeric VLP candidates or VLPs.
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NOMENCLATURE
A260/A280 absorbance ratio 260 to 280 nm
CFF cross‐flow filtration
DF diafiltration
DisA‐OC disassembly on column
DisA‐TS disassembly time series
DV diafiltration volumes
HBcAg hepatitis B core antigen
HMWS high‐molecular‐weight species
HPLC high‐performance liquid chromatography
LMWS low‐molecular‐weight species




ci concentration of component i
c̄i average concentration of component i
c~i measured concentration of component i
fv evaporation correction factor
k0,j disassembly rate, further specified by j
Ri apparent retention coefficient of component i
rv volumetric solvent evaporation rate
t0 time of the start of the experiment
t , tj time after start of the experiment (further specified by j ≠ 0)
−tj average time, further specified by j
V , Vj volume (further specified by j)




Beynon, R. J., & Easterby, J. S. (1996). Buffer solutions (1st ed.). Oxford
University Press Inc. https://doi.org/10.4324/9780203494691
Billaud, J.‐N., Peterson, D., Barr, M., Chen, A., Sallberg, M., Garduno, F.,
Goldstein, P., McDowell, W., Hughes, J., Jones, J., & Milich, D. (2005).
Combinatorial approach to hepadnavirus‐like particle vaccine
design. Journal of Virology, 79(21), 13656–13666. https://doi.org/
10.1128/JVI.79.21.13656
Bin Mohamed Suffian, I. F., Garcia‐Maya, M., Brown, P., Bui, T.,
Nishimura, Y., Palermo, A. R., Ogino, C., Kondo, A., & Al‐Jamal, K. T.
(2017). Yield optimisation of hepatitis B virus core particles in E. coli
expression system for drug delivery applications. Scientific Reports,
7(1), 43160. https://doi.org/10.1038/srep43160
Borisova, G., Borschukova, O., Skrastina, D., Dislers, A., Ose, V.,
Pumpens, P., & Grens, E. (1999). Behavior of a short preS1 epitope
on the surface of hepatitis B core particles. Biological Chemistry,
380(3), 315–324. https://doi.org/10.1515/BC.1999.043
Bryan, J. T., Buckland, B., Hammond, J., & Jansen, K. U. (2016). Prevention
of cervical cancer: Journey to develop the first human
papillomavirus virus‐like particle vaccine and the next generation
vaccine. Current Opinion in Chemical Biology, 32, 34–47. https://doi.
org/10.1016/j.cbpa.2016.03.001
Bull, H. B., Breese, K., Ferguson, G. L., & Swenson, C. A. (1964). The pH of
urea solutions. Archives of Biochemistry and Biophysics, 104(2),
297–304. https://doi.org/10.1016/S0003-9861(64)80017-5
Böttcher, B., Vogel, M., Ploss, M., & Nassal, M. (2006). High plasticity of
the hepatitis B virus capsid revealed by conformational stress.
Journal of Molecular Biology, 356(3), 812–822. https://doi.org/10.
1016/j.jmb.2005.11.053
Ceres, P., & Zlotnick, A. (2002). Weak protein−protein interactions are
sufficient to drive assembly of hepatitis B virus capsids. Biochemistry,
41(39), 11525–11531. https://doi.org/10.1021/bi0261645
12 | HILLEBRANDT ET AL.
Chackerian, B. (2007). Virus‐like particles: Flexible platforms for vaccine
development. Expert Review of Vaccines, 6(3), 381–390. https://doi.
org/10.1586/14760584.6.3.381
Crowther, R. A., Kiselev, N. A., Böttcher, B., Berriman, J. A., Borisova, G. P.,
Ose, V., & Pumpens, P. (1994). Three‐dimensional structure of
hepatitis B virus core particles determined by electron
cryomicroscopy. Cell, 77(6), 943–950. https://doi.org/10.1016/
0092-8674(94)90142-2
Ding, Y., Chuan, Y. P., He, L., & Middelberg, A. P. J. (2010). Modeling the
competition between aggregation and self‐assembly during virus‐
like particle processing. Biotechnology and Bioengineering, 107(3),
550–560. https://doi.org/10.1002/bit.22821
Donovan, J. W. (1969). Ultraviolet absorption. In S. J. Leach (Ed.), Physical
principles and techniques of protein chemistry (1st ed, pp. 101–170).
New York: Academic Press. https://doi.org/10.1016/B978-0-12-
440101-3.50009-6
European Medicines Agency. (2015). European public assessment reports:
Mosquirix. https://www.ema.europa.eu/en/documents/medicine-
outside-eu/mosquirix-summary-public_en.pdf
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R.,
Appel, R. D., & Bairoch, A. (2005). Protein Identification and analysis
tools on the ExPASy server. In J. M. Walker (Ed.), The proteomics
protocols handbook (pp. 571–607). Humana Press. https://doi.org/10.
1385/1-59259-890-0:571
Gerstweiler, L., Bi, J., & Middelberg, A. (2021). Virus‐like particle
preparation is improved by control over capsomere‐DNA
interactions during chromatographic purification. Biotechnology and
Bioengineering, 118, 1688–1701. https://doi.org/10.1002/bit.27687
Ghorbani, A., Zare, F., Sazegari, S., Afsharifar, A., Eskandari, M. H., &
Pormohammad, A. (2020). Development of a novel platform of virus‐like
particle (VLP)‐based vaccine against COVID‐19 by exposing epitopes:
An immunoinformatics approach. New Microbes and New Infections, 38,
100786. https://doi.org/10.1016/j.nmni.2020.100786
Hillebrandt, N., Vormittag, P., Bluthardt, N., Dietrich, A., & Hubbuch, J.
(2020). Integrated process for capture and purification of virus‐like
particles: Enhancing process performance by cross‐flow filtration.
Frontiers in Bioengineering and Biotechnology, 8, 8. https://doi.org/10.
3389/fbioe.2020.00489
Holmes, K., Shepherd, D. A., Ashcroft, A. E., Whelan, M., Rowlands, D. J., &
Stonehouse, N. J. (2015). Assembly pathway of hepatitis B core
virus‐like particles from genetically fused dimers. Journal of
Biological Chemistry, 290(26), 16238–16245. https://doi.org/10.
1074/jbc.M114.622035
Jegerlehner, A. (2002). A molecular assembly system that renders
antigens of choice highly repetitive for induction of protective B
cell responses. Vaccine, 20(25–26), 3104–3112. https://doi.org/10.
1016/S0264-410X(02)00266-9
Karpenko, L. I., Ivanisenko, V. A., Pika, I. A., Chikaev, N. A., Eroshkin, A. M.,
Veremeiko, T. A., & Ilyichev, A. A. (2000). Insertion of foreign epitopes in
HBcAg: How to make the chimeric particle assemble. Amino Acids, 18(4),
329–337. https://doi.org/10.1007/s007260070072
Kawahara, K., & Tanford, C. (1966). Viscosity and density of aqueous
solutions of urea and guanidine hydrochloride. Journal of Biological
Chemistry, 241(13), 3228–3232. https://doi.org/10.1016/S0021-
9258(18)96519-1
Kurnik, R. T., Yu, A. W., Blank, G. S., Burton, A. R., Smith, D., Athalye, A. M.,
& van Reis, R. (1995). Buffer exchange using size exclusion
chromatography, countercurrent dialysis, and tangential flow
filtration: Models, development, and industrial application.
Biotechnology and Bioengineering, 45(2), 149–157. https://doi.org/
10.1002/bit.260450209
Layne, E. (1957). Spectrophotometric and turbidimetric methods for
measuring proteins. In S. P. Colowick & N. O. Kaplan (Eds.), Methods
in enzymology (Vol. 3, pp. 447–454). Academic Press. https://doi.org/
10.1016/S0076-6879(57)03413-8
Lee, K. W., & Tan, W. S. (2008). Recombinant hepatitis B virus core particles:
Association, dissociation and encapsidation of green fluorescent protein.
Journal of Virological Methods, 151(2), 172–180. https://doi.org/10.1016/
j.jviromet.2008.05.025
Liew, M. W. O., Chuan, Y. P., & Middelberg, A. P. J. (2012). Reactive
diafiltration for assembly and formulation of virus‐like particles.
Biochemical Engineering Journal, 68, 120–128. https://doi.org/10.
1016/j.bej.2012.07.009
Mach, H., Volkin, D. B., Troutman, R. D., Wang, B.B., Luo, Z., Jansen, K. U.,
& Shi, L. (2006). Disassembly and reassembly of yeast‐derived
recombinant human papillomavirus virus‐like particles (HPV VLPs).
Journal of Pharmaceutical Sciences, 95(10), 2195–2206. https://doi.
org/10.1002/jps.20696
McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E.,
Miller, W. J., & Hilleman, M. R. (1984). Human hepatitis B vaccine
from recombinant yeast. Nature, 307(5947), 178–180. https://doi.
org/10.1038/307178a0
McCarthy, M. P., White, W. I., Palmer‐Hill, F., Koenig, S., & Suzich, J. A.
(1998). Quantitative disassembly and reassembly of human
papillomavirus type 11 virus‐like particles in vitro. Journal of
Virology, 72(1), 32–41. https://doi.org/10.1128/JVI.72.1.32-41.1998
Meireles, M., Aimar, P., & Sanchez, V. (1991). Effects of protein fouling on
the apparent pore size distribution of sieving membranes. Journal of
Membrane Science, 56(1), 13–28. https://doi.org/10.1016/0376-
7388(91)85013-U
Nassal, M., Skamel, C., Kratz, P. A., Wallich, R., Stehle, T., & Simon, M. (2005). A
fusion product of the complete Borrelia burgdorferi outer surface protein
A (OspA) and the hepatitis B virus capsid protein is highly immunogenic
and induces protective immunity similar to that seen with an effective
lipidated OspA vaccine formula. European Journal of Immunology, 35(2),
655–665. https://doi.org/10.1002/eji.200425449
Newman, M., Chua, P. K., Tang, F.‐M., Su, P.‐Y., & Shih, C. (2009). Testing
an electrostatic interaction hypothesis of hepatitis B virus capsid
stability by using an in vitro capsid disassembly/reassembly system.
Journal of Virology, 83(20), 10616–10626. https://doi.org/10.1128/
JVI.00749-09
Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., & Gray, T. (1995). How to
measure and predict the molar absorption coefficient of a protein.
Protein Science, 4(11), 2411–2423. https://doi.org/10.1002/pro.
5560041120
Phillips, A. T., & Signs, M. W. (2004). Desalting, concentration, and buffer
exchange by dialysis and ultrafiltration. Current Protocols in Protein
Science, 38(1), 1–15. https://doi.org/10.1002/0471140864.ps0404s38
Porterfield, J. Z., & Zlotnick, A. (2010). A simple and general method for
determining the protein and nucleic acid content of viruses by UV
absorbance. Virology, 407(2), 281–288. https://doi.org/10.1016/j.
virol.2010.08.015
Pumpens, P., & Grens, E. (2001). HBV core particles as a carrier for B cell/
T cell epitopes. Intervirology, 44(2–3), 98–114. https://doi.org/10.
1159/000050037
Rosenberg, E., Hepbildikler, S., Kuhne, W., & Winter, G. (2009).
Ultrafiltration concentration of monoclonal antibody solutions:
Development of an optimized method minimizing aggregation.
Journal of Membrane Science, 342(1–2), 50–59. https://doi.org/10.
1016/j.memsci.2009.06.028
Rüdt, M., Vormittag, P., Hillebrandt, N., & Hubbuch, J. (2019). Process
monitoring of virus‐like particle reassembly by diafiltration with UV/Vis
spectroscopy and light scattering. Biotechnology and Bioengineering,
116(6), 1366–1379. https://doi.org/10.1002/bit.26935
Samandoulgou, I., Hammami, R., Morales Rayas, R., Fliss, I., & Jean, J.
(2015). Stability of secondary and tertiary structures of virus‐like
particles representing noroviruses: Effects of pH, ionic strength, and
temperature and implications for adhesion to surfaces. Applied and
Environmental Microbiology, 81(22), 7680–7686. https://doi.org/10.
1128/AEM.01278-15
HILLEBRANDT ET AL. | 13
Schumacher, J., Bacic, T., Staritzbichler, R., Daneschdar, M., Klamp, T.,
Arnold, P., Jägle, S., Türeci, Ö., Markl, J., & Sahin, U. (2018). Enhanced
stability of a chimeric hepatitis B core antigen virus‐like‐particle (HBcAg‐
VLP) by a C‐terminal linker‐hexahistidine‐peptide. Journal of
Nanobiotechnology, 16(1), 39. https://doi.org/10.1186/s12951-018-
0363-0
Shi, L., Sanyal, G., Ni, A., Luo, Z., Doshna, S., Wang, B., Graham, T. L., Wang, N.,
& Volkin, D. B. (2005). Stabilization of human papillomavirus virus‐like
particles by non‐ionic surfactants. Journal of Pharmaceutical Sciences,
94(7), 1538–1551. https://doi.org/10.1002/jps.20377
Singh, S., & Zlotnick, A. (2003). Observed hysteresis of virus capsid
disassembly is implicit in kinetic models of assembly. Journal of
Biological Chemistry, 278(20), 18249–18255. https://doi.org/10.
1074/jbc.M211408200
Strods, A., Ose, V., Bogans, J., Cielens, I., Kalnins, G., Radovica, I.,
Kazaks, A., Pumpens, P., & Renhofa, R. (2015). Preparation by
alkaline treatment and detailed characterisation of empty hepatitis
B virus core particles for vaccine and gene therapy applications.
Scientific Reports, 5(1), 11639. https://doi.org/10.1038/srep11639
van Reis, R., Goodrich, E. M., Yson, C. L., Frautschy, L. N., Whiteley, R., &
Zydney, A. L. (1997). Constant Cwall ultrafiltration process control.
Journal of Membrane Science, 130(1–2), 123–140. https://doi.org/10.
1016/S0376-7388(97)00012-4
van Reis, R., & Zydney, A. L. (2010). Protein ultrafiltration. In M. C. Flickinger
(Ed.), Encyclopedia of industrial biotechnology (pp. 1–20). John Wiley &
Sons, Inc. https://doi.org/10.1002/9780470054581.eib515
Vormittag, P., Klamp, T., & Hubbuch, J. (2020a). Ensembles of
hydrophobicity scales as potent classifiers for chimeric virus‐like
particle solubility—An amino acid sequence‐based machine learning
approach. Frontiers in Bioengineering and Biotechnology, 8, 395, 1–15.
https://doi.org/10.3389/fbioe.2020.00395
Vormittag, P., Klamp, T., & Hubbuch, J. (2020b). Optimization of a soft
ensemble vote classifier for the prediction of chimeric virus‐like
particle solubility and other biophysical properties. Frontiers in
Bioengineering and Biotechnology, 8, 881. https://doi.org/10.3389/
fbioe.2020.00881
Yang, Y., Shi, W., Abiona, O. M., Nazzari, A., Olia, A. S., Ou, L., Phung, E.,
Stephens, T., Tsybovsky, Y., Verardi, R., Wang, S., Werner, A., Yap, C.,
Ambrozak, D., Bylund, T., Liu, T., Nguyen, R., Wang, L., Zhang, B., …
Kwong, P. D. (2021). Newcastle disease virus‐like particles displaying
prefusion‐stabilized SARS‐CoV‐2 spikes elicit potent neutralizing
responses. Vaccines, 9(2), 73. https://doi.org/10.3390/vaccines9020073
Zhang, Y., Liu, Y., Zhang, B., Yin, S., Li, X., Zhao, D., Wang, W., Bi, J., & Su, Z.
(2021). In vitro preparation of uniform and nucleic acid free
hepatitis B core particles through an optimized disassembly‐
purification‐reassembly process. Protein Expression and Purification,
178, 105747. https://doi.org/10.1016/j.pep.2020.105747
Zhao, Q., Allen, M. J., Wang, Y., Wang, B., Wang, N., Shi, L., & Sitrin, R. D.
(2012). Disassembly and reassembly improves morphology and thermal
stability of human papillomavirus type 16 virus‐like particles.
Nanomedicine: Nanotechnology, Biology, and Medicine, 8(7), 1182–1189.
https://doi.org/10.1016/j.nano.2012.01.007
Zhao, Q., Modis, Y., High, K., Towne, V., Meng, Y., Wang, Y., Alexandroff, J.,
Brown, M., Carragher, B., Potter, C. S., Abraham, D., Wohlpart, D.,
Kosinski, M., Washabaugh, M. W., & Sitrin, R. D. (2012). Disassembly
and reassembly of human papillomavirus virus‐like particles
produces more virion‐like antibody reactivity. Virology Journal,
9(1), 52. https://doi.org/10.1186/1743-422X-9-52
Zlotnick, A., Ceres, P., Singh, S., & Johnson, J. M. (2002). A small molecule
inhibits and misdirects assembly of hepatitis B virus capsids. Journal
of Virology, 76(10), 4848–4854. https://doi.org/10.1128/JVI.76.10.
4848-4854.2002
Zlotnick, A., Cheng, N., Conway, J. F., Booy, F. P., Steven, A. C., Stahl, S. J., &
Wingfield, P. T. (1996). Dimorphism of hepatitis B virus capsids is
strongly influenced by the C‐terminus of the capsid protein. Biochemistry,
35(23), 7412–7421. https://doi.org/10.1021/bi9604800
Zlotnick, A., Cheng, N., Stahl, S. J., Conway, J. F., Steven, A. C., &
Wingfield, P. T. (1997). Localization of the C terminus of the
assembly domain of hepatitis B virus capsid protein: Implications for
morphogenesis and organization of encapsidated RNA. Proceedings
of the National Academy of Sciences of the United States of America,
94(18), 9556–9561. https://doi.org/10.1073/pnas.94.18.9556
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the sup-
porting information tab for this article.
How to cite this article: Hillebrandt, N., Vormittag, P.,
Dietrich, A., Wegner, C. H., & Hubbuch, J. (2021). Process
development for cross‐flow diafiltration‐based VLP
disassembly: A novel high‐throughput screening approach.
Biotechnology and Bioengineering, 1–15.
https://doi.org/10.1002/bit.27868
APPENDIX A
DERIVATION OF THE EVAPORATION CORRECTION FACTORS
(EQUATION 2)
The calculation of the evaporation correction factor requires a prior





V t V t
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where V is the solution volume, t0 the starting time, and tv the end of
the observed interval. Note that rv is negative in this case and as-
sumed to be constant over time. Proteins, such as HBcAg, do not
evaporate and therefore mass conservation holds
=V t c t V t c t( ) ¯ ( ) ( ) ¯ ( ),0 HBcAg 0 v HBcAg v (A2)
where c̄HBcAg is the average HBcAg concentration of multiple ob-
servations and disassembly conditions. Substituting V t( )v in Equation




















For the DisA‐TS, this previously determined mean evaporation rate
is then used to compare the evaporation‐corrected sample volume
V t( )c at a time t with a theoretical sample volume V t( )th . The latter is
solely based on volume reduction by sampling (drawn injections)
from the initial volume. The reduced volumes V t( )c and their relation
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where −t t( )0 is the current experiment duration. For example,
considering an initial volume of 500 µL and a second sample after
60min (one 20 µL sampling already passed), a theoretical volume of
= − =V 500 μL 20 μL 480 μLth is expected when neglecting evapora-
tion. Including an evaporation rate would lead to a smaller corrected
volume of = + −V r t t480 μL ( )c v 0 , where − =t t( ) 60 min0 . While in
this case, the influence of evaporation is small, it increases for later
samples.
Due to volume reduction, the measured dimer concentration
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Substituting Equation (A4) into (A5) leads to Equation (2). A potential
error of this evaporation correction approach is the neglected influence
of differing urea concentrations and pH on evaporation. Furthermore, an
increase in urea or buffer species concentration due to evaporation
during the DisA‐TS was neglected. The maximum urea concentration
increase is expected for conditions with =c 4 Murea at 24 h, which
amounts to 0.3 M.
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